TOMAS CHAO: Open Payments
NPI 1316003577 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461,233 in 852 payments from 20 companies in 2025. Trend: 2023 $416,897 · 2024 $509,683 · 2025 $461,233
Speaker / faculty: $326,364Travel & lodging: $58,068Consulting: $40,410Honoraria: $20,650Food & beverage: $12,825Speaker / faculty: $2,672
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 158 | $95,571 |
| Janssen Biotech, Inc. | 106 | $87,614 |
| UCB, Inc. | 126 | $67,577 |
| ABBVIE INC. | 67 | $31,750 |
| Incyte Corporation | 51 | $27,282 |
| GENZYME CORPORATION | 45 | $25,213 |
| Organon LLC | 48 | $24,391 |
| Arcutis Biotherapeutics, Inc. | 55 | $23,688 |
| Regeneron Healthcare Solutions, Inc. | 23 | $17,111 |
| E.R. Squibb & Sons, L.L.C. | 36 | $15,896 |
Products named: EBGLYSS, TREMFYA, Bimzelx, DUPIXENT, Zoryve, VTAMA, SKYRIZI, Sotyktu.
Industry payments across GA — which companies pay providers there.
